|
US5650270A
(en)
*
|
1982-02-01 |
1997-07-22 |
Northeastern University |
Molecular analytical release tags and their use in chemical analysis
|
|
US5516931A
(en)
*
|
1982-02-01 |
1996-05-14 |
Northeastern University |
Release tag compounds producing ketone signal groups
|
|
US4709016A
(en)
*
|
1982-02-01 |
1987-11-24 |
Northeastern University |
Molecular analytical release tags and their use in chemical analysis
|
|
DE3545398A1
(de)
*
|
1985-12-20 |
1987-06-25 |
Boehringer Mannheim Gmbh |
Verfahren zur steigerung der quanten-ausbeute bei der oxidation von luminol durch peroxide in gegenwart von peroxidase
|
|
US4937188A
(en)
*
|
1986-04-15 |
1990-06-26 |
Northeastern University |
Enzyme activity amplification method for increasing assay sensitivity
|
|
US5190864A
(en)
*
|
1986-04-15 |
1993-03-02 |
Northeastern University |
Enzyme amplification by using free enzyme to release enzyme from an immobilized enzyme material
|
|
US5034317A
(en)
*
|
1987-01-30 |
1991-07-23 |
Polaroid Corporation |
Enzyme controlled release system and organic conjugate reactant
|
|
WO1988006732A1
(en)
*
|
1987-03-02 |
1988-09-07 |
Allied Corporation |
Tagged binding reagents and methods for detecting target analytes
|
|
US5057301A
(en)
*
|
1988-04-06 |
1991-10-15 |
Neorx Corporation |
Modified cellular substrates used as linkers for increased cell retention of diagnostic and therapeutic agents
|
|
EP0603266B1
(en)
*
|
1991-08-23 |
1999-05-12 |
Molecular Probes, Inc. |
Use of haloalkyl derivatives of reporter molecules to analyze metabolic activity in cells
|
|
DE69328080T2
(de)
*
|
1992-07-27 |
2000-12-14 |
Kurabo Industries Ltd., Kurashiki |
Verfahren zum hochempfindlichen nachweis von aminosäurederivaten
|
|
US6503759B1
(en)
|
1992-10-01 |
2003-01-07 |
The Trustees Of Columbia University In The City Of New York |
Complex combinatorial chemical libraries encoded with tags
|
|
US5721099A
(en)
*
|
1992-10-01 |
1998-02-24 |
Trustees Of Columbia University In The City Of New York |
Complex combinatorial chemical libraries encoded with tags
|
|
US5565324A
(en)
*
|
1992-10-01 |
1996-10-15 |
The Trustees Of Columbia University In The City Of New York |
Complex combinatorial chemical libraries encoded with tags
|
|
US6936447B1
(en)
|
2000-04-03 |
2005-08-30 |
University Of Iowa Research Foundation |
Autoinducer molecule
|
|
JP2727289B2
(ja)
*
|
1993-09-29 |
1998-03-11 |
呉羽化学工業株式会社 |
3−デオキシグルコソン誘導体及びその定量法
|
|
CN1525171A
(zh)
*
|
1993-10-01 |
2004-09-01 |
ŦԼ�и��ױ��Ǵ�ѧ���� |
用标示物编码的多元组合化学库
|
|
US6936477B2
(en)
|
1994-04-13 |
2005-08-30 |
The Trustees Of Columbia University In The City Of New York |
Complex combinatorial chemical libraries encoded with tags
|
|
US5994067A
(en)
*
|
1995-11-14 |
1999-11-30 |
The United States Of America As Represented By The Secretary Of The Army |
Method and kit for rapid detection of toxins and bacteria
|
|
US6027890A
(en)
*
|
1996-01-23 |
2000-02-22 |
Rapigene, Inc. |
Methods and compositions for enhancing sensitivity in the analysis of biological-based assays
|
|
PL328272A1
(en)
*
|
1996-01-23 |
1999-01-18 |
Rapigene Inc |
Methods of and compositions for detecting ligand pair bonds using non-fluoroscent labelling
|
|
EP0962464A3
(en)
*
|
1996-01-23 |
2004-02-11 |
Qiagen Genomics, Inc. |
Methods and compositions for detecting binding of ligand pair using non-fluorescent label
|
|
US6613508B1
(en)
*
|
1996-01-23 |
2003-09-02 |
Qiagen Genomics, Inc. |
Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques
|
|
US6312893B1
(en)
|
1996-01-23 |
2001-11-06 |
Qiagen Genomics, Inc. |
Methods and compositions for determining the sequence of nucleic acid molecules
|
|
ATE191515T1
(de)
*
|
1996-01-23 |
2000-04-15 |
Rapigene Inc |
Verfahren und zusammensetzungen zum analysieren von nukleinsäuremolekulen mittels bemessungstechniken
|
|
WO1998026095A1
(en)
|
1996-12-10 |
1998-06-18 |
Genetrace Systems Inc. |
Releasable nonvolatile mass-label molecules
|
|
WO1998052961A1
(en)
*
|
1997-05-19 |
1998-11-26 |
Mirus Corporation |
Method for single-step attachment of a label to target molecules
|
|
US6455031B1
(en)
|
1997-06-18 |
2002-09-24 |
David G Davies |
Methods and compositions for controlling biofilm development
|
|
US6756404B2
(en)
*
|
1998-06-18 |
2004-06-29 |
The Research & Development Institute, Inc. |
Autoinducer compounds
|
|
US6514700B1
(en)
*
|
1999-04-30 |
2003-02-04 |
Aclara Biosciences, Inc. |
Nucleic acid detection using degradation of a tagged sequence
|
|
US6322980B1
(en)
*
|
1999-04-30 |
2001-11-27 |
Aclara Biosciences, Inc. |
Single nucleotide detection using degradation of a fluorescent sequence
|
|
US20040248150A1
(en)
*
|
1999-04-02 |
2004-12-09 |
Sharat Singh |
Methods employing oligonucleotide-binding e-tag probes
|
|
US6627400B1
(en)
|
1999-04-30 |
2003-09-30 |
Aclara Biosciences, Inc. |
Multiplexed measurement of membrane protein populations
|
|
US6649351B2
(en)
|
1999-04-30 |
2003-11-18 |
Aclara Biosciences, Inc. |
Methods for detecting a plurality of analytes by mass spectrometry
|
|
US20030235832A1
(en)
*
|
2000-06-21 |
2003-12-25 |
Ahmed Chenna |
Multiplexed analysis by chromatographic separation of molecular tags
|
|
US6673550B2
(en)
|
1999-04-30 |
2004-01-06 |
Aclara Biosciences, Inc. |
Electrophoretic tag reagents comprising fluorescent compounds
|
|
US7001725B2
(en)
|
1999-04-30 |
2006-02-21 |
Aclara Biosciences, Inc. |
Kits employing generalized target-binding e-tag probes
|
|
US7160735B2
(en)
*
|
2000-04-28 |
2007-01-09 |
Monogram Biosciences, Inc. |
Tagged microparticle compositions and methods
|
|
US7771929B2
(en)
*
|
2000-04-28 |
2010-08-10 |
Monogram Biosciences, Inc. |
Tag library compounds, compositions, kits and methods of use
|
|
US20030207300A1
(en)
*
|
2000-04-28 |
2003-11-06 |
Matray Tracy J. |
Multiplex analytical platform using molecular tags
|
|
US7537938B2
(en)
*
|
2000-04-28 |
2009-05-26 |
Monogram Biosciences, Inc. |
Biomarker detection in circulating cells
|
|
US6632606B1
(en)
|
2000-06-12 |
2003-10-14 |
Aclara Biosciences, Inc. |
Methods for single nucleotide polymorphism detection
|
|
US7163918B2
(en)
*
|
2000-08-22 |
2007-01-16 |
New River Pharmaceuticals Inc. |
Iodothyronine compositions
|
|
WO2002018342A2
(en)
*
|
2000-08-31 |
2002-03-07 |
The University Of Iowa Research Foundation |
Novel autoinducer molecules and uses therefor
|
|
AU2002305658A1
(en)
|
2001-05-21 |
2002-12-03 |
Aclara Biosciences, Inc. |
Analyzing phosphorylated proteins
|
|
JP2005505749A
(ja)
|
2001-05-21 |
2005-02-24 |
アクララ バイオサイエンシーズ, インコーポレイテッド |
タンパク質を分析するための方法および組成物
|
|
US7358052B2
(en)
*
|
2001-05-26 |
2008-04-15 |
Monogram Biosciences, Inc. |
Catalytic amplification of multiplexed assay signals
|
|
WO2003033741A1
(en)
*
|
2001-10-16 |
2003-04-24 |
Aclara Biosciences, Inc. |
Universal e-tag primer and probe compositions and methods
|
|
US7045311B2
(en)
*
|
2001-10-25 |
2006-05-16 |
Monogram Biosciences, Inc. |
Whole cell assay systems for cell surface proteases
|
|
CN1166422C
(zh)
*
|
2001-11-05 |
2004-09-15 |
北京源德生物医学工程股份有限公司 |
用于体外高能聚焦超声波治疗机的坐位架
|
|
US20050053939A1
(en)
*
|
2001-11-09 |
2005-03-10 |
Ahmed Chenna |
Methods and compositions for enhancing detection in determinations employing cleavable electrophoretic tag reagents
|
|
JP2006509183A
(ja)
*
|
2002-03-05 |
2006-03-16 |
アクララ バイオサイエンシーズ, インコーポレイテッド |
膜結合増感剤を用いる多重分析
|
|
US7105308B2
(en)
*
|
2002-07-25 |
2006-09-12 |
Monogram Biosciences, Inc. |
Detecting receptor oligomerization
|
|
US7402397B2
(en)
*
|
2002-05-21 |
2008-07-22 |
Monogram Biosciences, Inc. |
Detecting and profiling molecular complexes
|
|
US20040229293A1
(en)
*
|
2002-05-21 |
2004-11-18 |
Po-Ying Chan-Hui |
Surface receptor complexes as biomarkers
|
|
US20040229299A1
(en)
*
|
2002-05-21 |
2004-11-18 |
Badal M. Youssouf |
Intracellular complexes as biomarkers
|
|
US20040229294A1
(en)
|
2002-05-21 |
2004-11-18 |
Po-Ying Chan-Hui |
ErbB surface receptor complexes as biomarkers
|
|
US20040175765A1
(en)
*
|
2002-07-05 |
2004-09-09 |
Sharat Singh |
Cell-screening assay and composition
|
|
CA2493671A1
(en)
*
|
2002-07-26 |
2004-02-05 |
Aclara Biosciences, Inc. |
Lipophilic electrophoretic probes
|
|
DE10235602B4
(de)
|
2002-08-02 |
2010-01-14 |
Universität Duisburg-Essen |
Metallcluster-Nanoverbindungen zur Behandlung von Tumorerkrankungen
|
|
JP2007504482A
(ja)
*
|
2003-01-17 |
2007-03-01 |
アクララ バイオサイエンシーズ, インコーポレイテッド |
タグ付加分子ライブラリーを使用した受容体の脱オーファン化
|
|
US7402398B2
(en)
*
|
2003-07-17 |
2008-07-22 |
Monogram Biosciences, Inc. |
Measuring receptor homodimerization
|
|
CA2535510C
(en)
*
|
2003-08-11 |
2013-10-15 |
Monogram Biosciences, Inc. |
Detecting and profiling molecular complexes
|
|
CA2543830A1
(en)
*
|
2003-10-27 |
2005-05-19 |
Monogram Biosciences, Inc. |
Detecting human anti-therapeutic antibodies
|
|
EP1807436B1
(en)
|
2004-10-25 |
2014-06-18 |
Intezyne Technologies Inc. |
Heterobifunctional poly(ethylene glycol) and uses thereof
|
|
US7939267B2
(en)
*
|
2004-11-04 |
2011-05-10 |
Laboratory Corporation Of America Holdings |
Detection of activation of endothelial cells as surrogate marker for angiogenesis
|
|
NZ556290A
(en)
|
2005-01-04 |
2010-11-26 |
Intezyne Technologies Inc |
Synthesis of hybrid block copolymers and uses thereof
|
|
US20060211030A1
(en)
*
|
2005-03-16 |
2006-09-21 |
Sydney Brenner |
Methods and compositions for assay readouts on multiple analytical platforms
|
|
US20070149491A1
(en)
*
|
2005-05-17 |
2007-06-28 |
Findeis Mark A |
Compounds useful for treating neurodegenerative disorders
|
|
CA2609021C
(en)
*
|
2005-05-17 |
2013-07-09 |
Satori Pharmaceuticals, Inc. |
Compounds useful for treating neurodegenerative disorders
|
|
WO2008006097A2
(en)
*
|
2006-07-07 |
2008-01-10 |
Intezyne Technologies Llc |
Covalent modification of metal surfaces
|
|
US20120269728A1
(en)
*
|
2006-08-02 |
2012-10-25 |
Antara Biosciences Inc. |
Methods and compositions for detecting one or more target agents using tracking components
|
|
EP2073638B1
(en)
*
|
2006-11-20 |
2013-05-15 |
Satori Pharmaceuticals, Inc. |
Synthesis of compounds useful as modulators of amyloid-beta production
|
|
EP2083621A4
(en)
*
|
2006-11-20 |
2010-03-24 |
Satori Pharmaceuticals Inc |
MODULATORS OF AMYLOID BETA PRODUCTION
|
|
US7902345B2
(en)
|
2006-12-05 |
2011-03-08 |
Sequenom, Inc. |
Detection and quantification of biomolecules using mass spectrometry
|
|
US8133701B2
(en)
*
|
2006-12-05 |
2012-03-13 |
Sequenom, Inc. |
Detection and quantification of biomolecules using mass spectrometry
|
|
WO2008134761A2
(en)
*
|
2007-04-30 |
2008-11-06 |
Intezyne Technologies, Inc. |
Modification of biological targeting groups for the treatment of cancer
|
|
US8258190B2
(en)
*
|
2007-04-30 |
2012-09-04 |
Intezyne Technologies, Inc. |
Encapsulated contrast agents
|
|
EP2359862B1
(en)
|
2007-04-30 |
2013-07-24 |
Intezyne Technologies Inc. |
Hybrid block copolymer micelles with mixed stereochemistry for encapsulation of hydrophobic agents
|
|
EP2195452B1
(en)
|
2007-08-29 |
2012-03-14 |
Sequenom, Inc. |
Methods and compositions for universal size-specific polymerase chain reaction
|
|
US20100255607A1
(en)
*
|
2007-11-21 |
2010-10-07 |
Giese Roger W |
Affinity control of tagging noise
|
|
CA2711843C
(en)
|
2007-12-20 |
2018-11-13 |
Laboratory Corporation Of America Holdings |
Her-2 diagnostic methods
|
|
EP2283063A1
(en)
*
|
2008-04-30 |
2011-02-16 |
Intezyne Technologies Inc. |
Synthesis of hybrid block copolymers from difluoroacetate ammonium salts
|
|
SG10201510696RA
(en)
|
2008-06-27 |
2016-01-28 |
Celgene Avilomics Res Inc |
Heteroaryl compounds and uses thereof
|
|
US8338439B2
(en)
|
2008-06-27 |
2012-12-25 |
Celgene Avilomics Research, Inc. |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
|
KR101081053B1
(ko)
|
2008-07-18 |
2011-11-07 |
포항공과대학교 산학협력단 |
가변질량 라벨링제와 이를 이용한 아미노산 서열 및 단백질정량 동시 분석방법
|
|
US8470542B2
(en)
*
|
2008-12-01 |
2013-06-25 |
Laboratory Corporation Of America Holdings |
Methods and assays for measuring p95 and/or p95 complexes in a sample and antibodies specific for p95
|
|
SG172983A1
(en)
|
2009-01-15 |
2011-08-29 |
Lab Corp America Holdings |
Methods of determining patient response by measurement of her-3
|
|
CN102428069B
(zh)
|
2009-04-02 |
2014-04-02 |
盐野义制药株式会社 |
丙烯酰胺化合物及其用途
|
|
US9024766B2
(en)
*
|
2009-08-28 |
2015-05-05 |
The Invention Science Fund, Llc |
Beverage containers with detection capability
|
|
US8810417B2
(en)
*
|
2009-08-28 |
2014-08-19 |
The Invention Science Fund I, Llc |
Beverage immersate with detection capability
|
|
IN2012DN02534A
(da)
|
2009-09-16 |
2015-08-28 |
Avila Therapeutics Inc |
|
|
US20110269244A1
(en)
|
2009-12-30 |
2011-11-03 |
Petter Russell C |
Ligand-directed covalent modification of protein
|
|
US8703941B2
(en)
|
2011-01-10 |
2014-04-22 |
Nimbus Iris, Inc. |
IRAK inhibitors and uses thereof
|
|
JP6468838B2
(ja)
|
2011-05-19 |
2019-02-13 |
ラボラトリー コーポレイション オブ アメリカ ホールディングス |
癌患者の生存可能性を決定するためおよび癌患者における転移可能性を予測するための方法
|
|
EP3943087A1
(en)
|
2013-03-15 |
2022-01-26 |
Celgene CAR LLC |
Heteroaryl compounds and uses thereof
|
|
CN105264382A
(zh)
|
2013-04-05 |
2016-01-20 |
美国控股实验室公司 |
基于检测her3活化辅助癌症的诊断、预后和治疗的系统和方法
|
|
PT3049417T
(pt)
|
2013-07-31 |
2019-01-24 |
Merck Patent Gmbh |
Piridinas, pirimidinas e pirazinas, como inibidores de btk e utilizações das mesmas
|
|
RU2019131017A
(ru)
|
2013-10-21 |
2019-11-25 |
Мерк Патент Гмбх |
Соединения гетероарила в качестве ингибиторов btk и их применение
|
|
EP4019518A1
(en)
|
2014-02-28 |
2022-06-29 |
Nimbus Lakshmi, Inc. |
Tyk2 inhibitors and uses thereof
|
|
MA38393B1
(fr)
|
2014-03-13 |
2018-11-30 |
Sanofi Sa |
Composés hétéroaryle et utilisations associées
|
|
RS61853B1
(sr)
|
2014-10-29 |
2021-06-30 |
Bicyclerd Ltd |
Biciklični peptidni ligandi specifični za mt1-mmp
|
|
JP2017537327A
(ja)
|
2014-12-11 |
2017-12-14 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung |
Btk阻害剤のアッセイ
|
|
MA41198A
(fr)
|
2014-12-18 |
2017-10-24 |
Shire Human Genetic Therapies |
Essais d'activité enzymatique pour i2s
|
|
TWI788655B
(zh)
|
2015-02-27 |
2023-01-01 |
美商林伯士拉克許米公司 |
酪胺酸蛋白質激酶2(tyk2)抑制劑及其用途
|
|
WO2017004133A1
(en)
|
2015-06-29 |
2017-01-05 |
Nimbus Iris, Inc. |
Irak inhibitors and uses thereof
|
|
WO2017004134A1
(en)
|
2015-06-29 |
2017-01-05 |
Nimbus Iris, Inc. |
Irak inhibitors and uses thereof
|
|
JP6802263B2
(ja)
|
2015-09-02 |
2020-12-16 |
ニンバス ラクシュミ, インコーポレイテッド |
Tyk2阻害剤およびその使用
|
|
JP2019515252A
(ja)
|
2016-03-15 |
2019-06-06 |
ラボラトリー コーポレイション オブ アメリカ ホールディングス |
細胞間のタンパク質相互作用を評価する方法
|
|
CN115448916A
(zh)
|
2016-10-14 |
2022-12-09 |
林伯士拉克许米公司 |
Tyk2抑制剂及其用途
|
|
AU2017345736B2
(en)
|
2016-10-21 |
2022-04-07 |
Takeda Pharmaceutical Company Limited |
TYK2 inhibitors and uses thereof
|
|
US11730819B2
(en)
|
2016-12-23 |
2023-08-22 |
Bicycletx Limited |
Peptide derivatives having novel linkage structures
|
|
EP3615550A1
(en)
|
2017-04-27 |
2020-03-04 |
BicycleTx Limited |
Bicyclic peptide ligands and uses thereof
|
|
EP3645549A1
(en)
|
2017-06-26 |
2020-05-06 |
BicycleRD Limited |
Bicyclic peptide ligands with detectable moieties and uses thereof
|
|
JP7216705B2
(ja)
|
2017-07-28 |
2023-02-02 |
ニンバス ラクシュミ, インコーポレイテッド |
Tyk2阻害剤およびその使用方法
|
|
JP7670481B2
(ja)
|
2017-08-04 |
2025-04-30 |
バイスクルテクス・リミテッド |
Cd137に対して特異的な二環式ペプチドリガンド
|
|
US20200283482A1
(en)
|
2017-08-14 |
2020-09-10 |
Bicyclerd Limited |
Bicyclic peptide ligand prr-a conjugates and uses thereof
|
|
US20200291096A1
(en)
|
2017-08-14 |
2020-09-17 |
Bicyclerd Limited |
Bicyclic peptide ligand sting conjugates and uses thereof
|
|
US11358948B2
(en)
|
2017-09-22 |
2022-06-14 |
Kymera Therapeutics, Inc. |
CRBN ligands and uses thereof
|
|
WO2019060742A1
(en)
|
2017-09-22 |
2019-03-28 |
Kymera Therapeutics, Inc |
AGENTS FOR DEGRADING PROTEINS AND USES THEREOF
|
|
CN112739345A
(zh)
|
2017-11-06 |
2021-04-30 |
斯奈普生物公司 |
Pim激酶抑制剂组合物,方法和其用途
|
|
GB201721265D0
(en)
|
2017-12-19 |
2018-01-31 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for EphA2
|
|
TWI825046B
(zh)
|
2017-12-19 |
2023-12-11 |
英商拜西可泰克斯有限公司 |
Epha2特用之雙環胜肽配位基
|
|
IL315310A
(en)
|
2017-12-26 |
2024-10-01 |
Kymera Therapeutics Inc |
Irak degraders and uses thereof
|
|
US11485743B2
(en)
|
2018-01-12 |
2022-11-01 |
Kymera Therapeutics, Inc. |
Protein degraders and uses thereof
|
|
WO2019140387A1
(en)
|
2018-01-12 |
2019-07-18 |
Kymera Therapeutics, Inc. |
Crbn ligands and uses thereof
|
|
JP7229257B2
(ja)
|
2018-01-29 |
2023-02-28 |
メルク パテント ゲーエムベーハー |
Gcn2阻害剤およびその使用
|
|
KR20200115620A
(ko)
|
2018-01-29 |
2020-10-07 |
메르크 파텐트 게엠베하 |
Gcn2 억제제 및 이의 용도
|
|
KR20200128518A
(ko)
|
2018-02-23 |
2020-11-13 |
바이사이클티엑스 리미티드 |
다량체성 비사이클릭 펩타이드 리간드
|
|
US11180531B2
(en)
|
2018-06-22 |
2021-11-23 |
Bicycletx Limited |
Bicyclic peptide ligands specific for Nectin-4
|
|
GB201810316D0
(en)
|
2018-06-22 |
2018-08-08 |
Bicyclerd Ltd |
Peptide ligands for binding to EphA2
|
|
WO2020010177A1
(en)
|
2018-07-06 |
2020-01-09 |
Kymera Therapeutics, Inc. |
Tricyclic crbn ligands and uses thereof
|
|
WO2020010227A1
(en)
|
2018-07-06 |
2020-01-09 |
Kymera Therapeutics, Inc. |
Protein degraders and uses thereof
|
|
US11414431B2
(en)
|
2018-10-15 |
2022-08-16 |
Nimbus Lakshmi, Inc. |
Substituted pyrazolo[1,5-a]pyrimidines as TYK2 inhibitors
|
|
CN112955459A
(zh)
|
2018-10-23 |
2021-06-11 |
拜斯科技术开发有限公司 |
双环肽配体和其用途
|
|
CA3120866A1
(en)
|
2018-11-30 |
2020-06-04 |
Nimbus Lakshmi, Inc. |
Tyk2 inhibitors and uses thereof
|
|
CA3119773A1
(en)
|
2018-11-30 |
2020-06-04 |
Kymera Therapeutics, Inc. |
Irak degraders and uses thereof
|
|
GB201820325D0
(en)
|
2018-12-13 |
2019-01-30 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for psma
|
|
GB201820295D0
(en)
|
2018-12-13 |
2019-01-30 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for MT1-MMP
|
|
GB201820288D0
(en)
|
2018-12-13 |
2019-01-30 |
Bicycle Tx Ltd |
Bicycle peptide ligaands specific for MT1-MMP
|
|
WO2020128527A1
(en)
|
2018-12-21 |
2020-06-25 |
Bicyclerd Limited |
Bicyclic peptide ligands specific for pd-l1
|
|
CN113474045A
(zh)
|
2018-12-21 |
2021-10-01 |
拜斯科技术开发有限公司 |
Pd-l1特异性的双环肽配体
|
|
GB201900529D0
(en)
|
2019-01-15 |
2019-03-06 |
Bicycletx Ltd |
Bicyclic peptide ligands specific for CD38
|
|
US11174264B2
(en)
|
2019-01-23 |
2021-11-16 |
Nimbus Lakshmi, Inc. |
TYK2 inhibitors and uses thereof
|
|
WO2020165600A1
(en)
|
2019-02-14 |
2020-08-20 |
Bicycletx Limited |
Bicyclic peptide ligand sting conjugates and uses thereof
|
|
JP2022527114A
(ja)
|
2019-04-05 |
2022-05-30 |
カイメラ セラピューティクス, インコーポレイテッド |
分解剤およびそれらの使用
|
|
US12521438B2
(en)
|
2019-06-10 |
2026-01-13 |
Kymera Therapeutics, Inc. |
SMARCA degraders and uses thereof
|
|
MX2021015995A
(es)
|
2019-06-28 |
2022-03-11 |
Kymera Therapeutics Inc |
Degradadores de cinasas asociadas al receptor de interleucina-1 (irak) y usos de los mismos.
|
|
US12558427B2
(en)
|
2019-07-17 |
2026-02-24 |
Kymera Therapeutics, Inc. |
IRAK degraders and uses thereof
|
|
TWI862640B
(zh)
|
2019-07-30 |
2024-11-21 |
英商拜西可泰克斯有限公司 |
異質雙環肽複合物
|
|
JP2022548594A
(ja)
|
2019-09-11 |
2022-11-21 |
ビンシア・バイオサイエンシーズ・インコーポレイテッド |
Usp30阻害剤及びその使用
|
|
CN119874700A
(zh)
|
2019-09-13 |
2025-04-25 |
林伯士萨顿公司 |
Hpk1拮抗剂和其用途
|
|
US12551564B2
(en)
|
2019-12-10 |
2026-02-17 |
Kymera Therapeutics, Inc. |
IRAK degraders and uses thereof
|
|
CN115052627A
(zh)
|
2019-12-17 |
2022-09-13 |
凯麦拉医疗公司 |
Irak降解剂和其用途
|
|
US11591332B2
(en)
|
2019-12-17 |
2023-02-28 |
Kymera Therapeutics, Inc. |
IRAK degraders and uses thereof
|
|
BR112022012410A2
(pt)
|
2019-12-23 |
2022-08-30 |
Kymera Therapeutics Inc |
Degradadores smarca e usos dos mesmos
|
|
US12569485B2
(en)
|
2019-12-23 |
2026-03-10 |
Kymera Therapeutics, Inc. |
SMARCA inhibitors and uses thereof
|
|
MX2022011602A
(es)
|
2020-03-19 |
2023-01-04 |
Kymera Therapeutics Inc |
Degradadores de la proteína de homólogo de ratón de minuto 2 (mdm2) y usos de los mismos.
|
|
TW202210483A
(zh)
|
2020-06-03 |
2022-03-16 |
美商凱麥拉醫療公司 |
Irak降解劑之結晶型
|
|
KR20230074119A
(ko)
|
2020-08-03 |
2023-05-26 |
바이사이클티엑스 리미티드 |
펩타이드 기반 링커
|
|
CA3202360A1
(en)
|
2020-12-30 |
2022-07-07 |
Nello Mainolfi |
Irak degraders and uses thereof
|
|
MX2023009059A
(es)
|
2021-02-02 |
2023-09-15 |
Liminal Biosciences Ltd |
Antagonistas de gpr84 y usos de estos.
|
|
CN117098757A
(zh)
|
2021-02-02 |
2023-11-21 |
里米诺生物科学有限公司 |
Gpr84拮抗剂和其用途
|
|
US12252488B2
(en)
|
2021-02-12 |
2025-03-18 |
Nimbus Saturn, Inc. |
HPK1 antagonists and uses thereof
|
|
CA3207049A1
(en)
|
2021-02-15 |
2022-08-18 |
Jared Gollob |
Irak4 degraders and uses thereof
|
|
US11926625B2
(en)
|
2021-03-05 |
2024-03-12 |
Nimbus Saturn, Inc. |
HPK1 antagonists and uses thereof
|
|
JP2024513011A
(ja)
|
2021-03-29 |
2024-03-21 |
ニンバス サターン, インコーポレイテッド |
Hpk1アンタゴニスト及びその使用
|
|
US12325697B2
(en)
|
2021-04-09 |
2025-06-10 |
Nimbus Clio, Inc. |
CBL-B modulators and uses thereof
|
|
KR20240020735A
(ko)
|
2021-05-07 |
2024-02-15 |
카이메라 쎄라퓨틱스 인코포레이티드 |
Cdk2 분해제 및 그 용도
|
|
CA3236262A1
(en)
|
2021-10-25 |
2023-05-04 |
Isaac Marx |
Tyk2 degraders and uses thereof
|
|
CA3236265A1
(en)
|
2021-10-29 |
2023-05-04 |
William Leong |
Irak4 degraders and synthesis thereof
|
|
US12091411B2
(en)
|
2022-01-31 |
2024-09-17 |
Kymera Therapeutics, Inc. |
IRAK degraders and uses thereof
|
|
CN119894873A
(zh)
|
2022-08-02 |
2025-04-25 |
里米诺生物科学有限公司 |
芳基三唑基和相关gpr84拮抗剂及其用途
|
|
KR20250056924A
(ko)
|
2022-08-02 |
2025-04-28 |
리미널 바이오사이언시스 리미티드 |
치환된 피리돈 gpr84 길항제 및 이의 용도
|
|
WO2025073871A1
(en)
|
2023-10-03 |
2025-04-10 |
Bicycletx Limited |
Bicyclic peptide ligand complexes specific for tfr1
|